D.S. Gray handles class action defense, products liability litigation, and commercial litigation. Manufacturers of vaccines, prescription medicines, medical devices, and construction materials have come to depend on D.S.’s creativity and skill in all phases of litigation.
D.S. takes an aggressive approach to all aspects of litigation, including, but not limited to, preliminary pretrial planning, initial motions practice, written discovery, deposition testimony, and briefing just prior to, during, and after trial. That demanding approach yields critical evidence for clients, weakens adversaries' claims, and leads to favorable results.
In products liability matters, D.S. focuses on translating complex legal, scientific, medical, and regulatory concepts into the plain language that winning arguments require. That philosophy has led to the dismissal of personal injury claims against the manufacturers of FDA-approved vaccines and prescription medicines based on governing state law, preemption principles, lack of subject matter jurisdiction, lack of personal jurisdiction, and/or lack of particularity. It also facilitates his collaboration with experts in advanced fields, such as immunology, epidemiology, otolaryngology, regulatory affairs, and hepatology.
In commercial litigation matters, D.S. has represented large institutional clients in the banking, education, consumer products, and steel industries in pretrial, trial, and appellate proceedings. He additionally counsels clients threatened with potential class action litigation based on consumer protection statutes and on insurance coverage matters.
D.S. also advises clients on proposed contract terminology, product safety, user warnings of product hazards, potential liabilities associated with their Internet presence, and gaps in insurance policies, to help limit potential litigation exposure.
D.S. serves on the board of directors for the Pro Bono Resource Center of Maryland. His significant pro bono matters also have included: